Skip to main content
. 2020 Jul 28;11:1505. doi: 10.3389/fimmu.2020.01505

Figure 4.

Figure 4

Correlation between anti-Ro52 and cGVHD target organ. Receiver operating characteristic (ROC) curve analysis to assess the association of anti-Ro52 levels in (A) patients with skin cGVHD vs. non-skin cGVHD, (B) patients with eyes cGVHD vs. non-eyes cGVHD, (C) patients with oral cGVHD vs. non-oral cGVHD, (D) patients with liver cGVHD vs. non-liver cGVHD, (E) patients with gastrointestinal cGVHD vs. non-gastrointestinal cGVHD, (F) patients with lungs cGVHD vs. non-lungs cGVHD, (G) patients with joints cGVHD vs. non-joints cGVHD, (H) patients with genital tract cGVHD vs. non-genital tract cGVHD. AUC, area under the curve. cGVHD, chronic GVHD.